From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA approves Biogen Idec treatment for hemophilia B

from The Wall Street Journal

The U.S. Food and Drug Administration has approved Biogen Idec Inc. treatment for hemophilia B, a largely inherited disorder that is the second-most common type of hemophilia. The investigational treatment—called Alprolix—won Canadian approval earlier this month. Alprolix is also under review by regulatory authorities in several other markets, including Japan and Australia. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063